Founded in the year 2001, Windlas Biotech provides pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers around the world
We employ 954 employees at our four state-of-the-art manufacturing facilities in Dehradun, Uttarakhand India. We also have a salesforce and distribution network spread across 14 states.
Windlas Biotech Limited IPO Details
|
|
---|---|
Issue Open | 04-08-2021 |
Issue Close | 06-08-2021 |
Allotment Date | 11-08-2021 |
Unblocked Amount | 12-08-2021 |
Credit Demat Amount | 13-08-2021 |
Listing Date | 16-08-2021 |
Issue Size |
87,29,130 Total Equity Share
35,87,056 Fresh Issue Equity Share 51,42,067 OFS Equity Share |
Issue Size | ₹ 401.54 Cr ₹ 165 Cr Fresh ₹ 236.54 Cr OFS |
IPO Price Band | ₹ 448 - ₹ 460 |
Minimum Share Bid | 30 |
Minimum Investment Amount [₹] | ₹ 13,800 |
Face Value | ₹ 5 |
Qualified Institutional Buyer [QIB] | 50 % |
High Networth Individual [HNI] | 15 % |
Retail Individual Investor [RII] | 35 % |
Listing On | BSE & NSE |
Windlas Biotech Limited IPO Related Link
|
---|
Windlas Biotech Limited IPO GMP Windlas Biotech Limited IPO Subscription Windlas Biotech Limited IPO Allotment Status |
Windlas Biotech Limited IPO Grey Market Premium
|
||||||
---|---|---|---|---|---|---|
Date | Offer Price | Premium | Kostak | Subject to Sauda | Listing Gain | Rating |
- | - | - | - | - | - | - |
- | - | - | - | - | - | - |
Windlas Biotech Limited IPO Financial Details (₹ in Cr)
|
||||
---|---|---|---|---|
Financial Year | Total Asset | Total Revenue | Total Expenses | Profit After Tax |
FY-2018 | 289.887 | 356.576 | 336.850 | 11.198 |
FY-2019 | 298.180 | 311.525 | 284.188 | 63.822 |
FY-2020 | 3384.88 | 313.339 | 299.205 | 16.213 |
FY-2021 | 315.883 | 430.70 | 387.17 | 15.62 |
Windlas Biotech Limited IPO Valuation Details
|
|
---|---|
Earnings Per Share [EPS] | ₹ 7.17 |
Price/Earnings [P/E] Ratio | 64.17 |
Return on Net Worth [RoNW] | 18.19 % |
Net Asset Value [NAV] | ₹ 109.36 Per Share |
Windlas Biotech Limited IPO Subscription Details
|
|||||
---|---|---|---|---|---|
As on Date | QIB | NII | RII | Total | |
Shared Offered | 17,23,700 | 13,23,766 | 30,88,786 | 61,36,252 | |
Day-1 [04-08-2021] |
0 [0] |
4,41,990 [0.33] |
1,86,52,440 [6.03] |
1,90,94,430 [3.111] |
|
Day-2 [05-08-2021] |
70,440 [0.04] |
14,79,510 [1.11] |
4,17,69,420 [13.52] |
4,33,19,370 [7.05] |
|
Day-3 [06-08-2021] |
4,20,65,880 [24.40] |
2,08,26,420 [15.73] |
7,44,51,090 [24.10] |
13,73,43,390 [22.38] |
Windlas Biotech Limited IPO Grey Market Premium
|
---|
Windlas Biotech Limited IPO Grey Market Premium :- Click Here |
Windlas Biotech Limited IPO Allotment Status
|
---|
Windlas Biotech Limited IPO Allotment Status :- Click Here |
Windlas Biotech Limited IPO Live Subscription
|
---|
Windlas Biotech Limited IPO Subscription in BSE:- Click Here to View Windlas Biotech Limited IPO Subscription in NSE:- Click Here to View |
Windlas Biotech Limited IPO Prospectus
|
---|
Windlas Biotech Limited IPO DRHP
Windlas Biotech Limited IPO RHP |
Windlas Biotech Limited IPO Contact Details
|
---|
Windlas Biotech Limited 705-706, Vatika Professional Point Sector-66, Golf Course Extension Road, Gurgaon 122 001, Haryana, India; Tel: +91 124 2821030 Website: www.windlasbiotech.com E-mail: grievance@windlasbiotech.com; Corporate Identity Number: U74899UR2001PLC033407 |
Windlas Biotech Limited IPO Registrar
|
---|
Link Intime India Private Limited C-101, 1st Floor 247 Park Lal Bhadur Shastri Marg Vikhroli (West) Mumbai 400 083 Maharashtra, India Tel: +91 22 4918 6200 E-mail: windlas.ipo@linkintime.co.in Website: www.linkintime.co.in Investor Grievance ID: windlas.ipo@linkintime.co.in Contact Person: Shanti Gopalkrishnan SEBI Registration Number: INR000004058 |
Windlas Biotech Limited IPO Lead Managers
|
---|
SBI Capital Markets Limited 202, Maker Tower ‘E’ Cuffe Parade Mumbai 400 005 Maharashtra, India Tel: +91 22 2217 8300 E-mail: windlas.ipo@sbicaps.com Website: www.sbicaps.com Investor Grievance ID: investor.relations@sbicaps.com Contact Person: Gaurav Mittal/Janardhan Wagle SEBI Registration Number: MB/INM000003531 DAM Capital Advisors Limited One BKC, Tower C, 15th IIFL Securities Limited 10th Floor, IIFL Centre th Floor, Unit No.1511 Bandra Kurla Complex, Bandra (East), Mumbai 400 051 Maharashtra, India Tel: +91 22 4202 2500 E-mail: windlas.ipo@damcapital.in Website: www.damcapital.in Investor Grievance ID: complaint@damcapital.in Contact Person: Chandresh Sharma SEBI Registration Number: MB/INM000011336 IIFL Securities Limited 10th Floor, IIFL Centre Kamala City, Senapati Bapat Marg Lower Parel (West) Mumbai 400 013 Maharashtra, India Tel: +91 22 4646 4600 E-mail: windlas.ipo@iiflcap.com Website: www.iiflcap.com Investor Grievance ID: ig.ib@iiflcap.com Contact Person: Aditya Agarwal/Harshvardhan Jain SEBI Registration Number: MB/INM000010940 |
Disclaimer:-
|
---|
• I request all investors, before applying for any IPO, please check the fundamentals and financial condition of the company and then applying to any IPO.
• www.liveipo.in will not be responsible for any kind of losses. So apply to any IPO at your risk
• We are not buying or selling any IPO forms regarding IPO Grey Market premium. We are only provide only recommendation of any IPO.
• Please do not subscribe to any IPO by just seeing the Grey Market Premium Price. It can change at any time.
|
0 Response to "Windlas Biotech Limited IPO Details"
Post a Comment